drugset / Trial / NCT00492947

Dendritic Cell Vaccine for Head and Neck Cancer

NCT00492947

RandomizedParallel-groupOpen-labelTreatment

Summary

This research study is testing a new treatment of cancer of the head and neck. Purpose This research study is being done to: 1. Test the safety of the experimental cancer vaccine made of dendritic cells. An experimental vaccine is one that is not approved by the Food and Drug Administration (FDA). 2. To learn what effects (good and bad) the vaccine will have on you and your head and neck cancer. 3. To learn if the vaccine will stimulate your body's white blood cells, which are part of your immune system (your body's natural defense system).

Timeline

Start
2007-06
Primary completion
2010-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DC vaccine Vaccine Other